Catalyst calendar
Data as of 2026-08-19 16:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2027-07-22 in 48w | $VRTX | Phase 2 | Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1… NCT07161037 |
| 2027-07-31 in 49w | $ALNY | Phase 1 | A Study to Evaluate ALN-4915 in Adult Healthy Volunteers NCT07535606 |
| 2027-08-07 in 50w | $BIIB | Phase 3 | A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults… NCT04856982 |
| 2027-08-09 in 51w | $ALNY | Phase 2 | A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy NCT06393712 |
| 2027-08-20 in 52w | $BNTX | Phase 4 | A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years… NCT07730450 |
| 2027-08-31 in 54w | $ALNY | Phase 1 | A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in… NCT06845202 |
| 2027-09-06 in 55w | $ZEAL | Early Phase 1 | A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability,… NCT07721597 |
| 2027-09-24 in 57w | $BIIB | Phase 3 | A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given… NCT05067790 |
| 2027-09-29 in 58w | $VIR | Phase 1 | Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in… NCT05997615 |
| 2027-09-30 in 58w | $VRTX | Phase 3 | Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis… NCT06460506 |
| 2027-09-30 in 58w | $BMRN | Phase 4 | Immune Modulation During Palynziq® Treatment in Adults (IMPALA) NCT07477691 |
| 2027-09-30 in 58w | $ALNY | Phase 1 | A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma NCT06600321 |
| 2027-10-07 in 59w | $ARGX | Phase 3 | A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP NCT07091630 |
| 2027-10-14 in 60w | $ITCI | Phase 2 | Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety… NCT06701903 |
| 2027-11-14 in 64w | $VRTX | Phase 3 | Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With… NCT05356195 |
| 2027-11-16 in 65w | $BIIB | Phase 3 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone… NCT06953583 |
| 2027-11-30 in 67w | $SRPT | Phase 1 | A First-in-human Study of the Effects of SRP-1005 in Participants With… NCT07536061 |
| 2027-12-14 in 69w | $ALNY | Phase 1 | A Study to Evaluate ALN-6222 in Participants With Obesity NCT07624071 |
| 2027-12-27 in 71w | $ALNY | Phase 3 | TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in… NCT07223203 |
| 2027-12-28 in 71w | $ITCI | Phase 2 | A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of… NCT06651567 |
| 2027-12-30 in 71w | $BEAM | Phase 1 | A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of… NCT06735755 |
| 2027-12-31 in 71w | $BPMC | Phase 4 | Avapritinib Rollover Study NCT06748001 |
| 2027-12-31 in 71w | $SRPT | Phase 1 | A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From… NCT04626674 |
| 2027-12-31 in 71w | $PTCT | Phase 3 | A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With… NCT05515536 |
| 2028-01-05 in 72w | $ALNY | Phase 1 | A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary… NCT06659640 |